Internal Medicine, Addiction Medicine · Savannah, GA
NPI
1205928355
Since 2006
Specialty
Internal Medicine, Addiction Medicine
Code 207RA0401X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
315 Commercial Dr, Suite B-3
Savannah, GA, 31406
Phone (912) 352-9902
Medicare paid, 2024
$39K
573 services
Medicare patients, 2024
52
Average age 68
Drug cost, 2024
$147K
1,589 prescriptions
Company payments, 2024
$37.7
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Daniel R Gaskin, Jr. was code 99214 (office e&m - established), 455 times for 52 patients. In total Daniel R Gaskin, Jr. billed 573 services in 3 codes, and Medicare paid $39K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-06-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 455 | 52 | $80.31 | $37K |
| 80305 Drug Tests | Office | 114 | 43 | $11.84 | $1,350 |
By year: 2022 $45K for 688 services; 2023 $41K for 628 services; 2024 $39K for 573 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 114 | 43 | $11.84 | $1,350 |
Medicare prescription drug claims, 2024
In 2024, the drug Daniel R Gaskin, Jr. prescribed most often to Medicare patients was Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl), with 607 prescriptions and refills. In total Daniel R Gaskin, Jr. wrote 1,589 Medicare prescriptions that cost $147K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone Buprenorphine Hcl/Naloxone Hcl | 607 | 614 | 67 | $77K |
| Buprenorphine Hcl Generic | 152 | 152 | 13 | $7,209 |
| Gabapentin Generic | 117 | 139 | 24 | $1,827 |
| Quetiapine Fumarate Generic | 92 | 120 | 14 | $1,511 |
| Trazodone Hcl Generic | 81 | 126 | 19 | $623 |
| Zubsolv Buprenorphine Hcl/Naloxone Hcl | 67 | 67 | Under 11 | $39K |
| Tizanidine Hcl Generic | 61 | 92 | 11 | $514 |
| Hydroxyzine Pamoate Generic | 46 | 46 | Under 11 | $243 |
| Pregabalin Generic | 32 | 38 | Under 11 | $1,401 |
| Oxcarbazepine Generic | 26 | 26 | Under 11 | $556 |
| Fluoxetine Hcl Generic | 22 | 32 | Under 11 | $92.69 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 21 | 21 | Under 11 | $206 |
| Duloxetine Hcl Generic | 21 | 35 | Under 11 | $162 |
| Suboxone Buprenorphine Hcl/Naloxone Hcl | 20 | 20 | Under 11 | $13K |
| Methadone Hcl Generic | 17 | 17 | Under 11 | $443 |
Brand drugs: 90 claims; generic drugs: 1,499 claims; opioid claims: 45.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Daniel R Gaskin, Jr. $37.7 ($37.7 in general payments such as food, travel and fees) from 1 company. The largest payer was Inspire Medical Systems, Inc. with $37.7.
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. INSP | 1 | $37.7 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.